For: | Guo CX, Huang X, Xu J, Zhang XZ, Shen YN, Liang TB, Bai XL. Combined targeted therapy and immunotherapy for cancer treatment. World J Clin Cases 2021; 9(26): 7643-7652 [PMID: 34621816 DOI: 10.12998/wjcc.v9.i26.7643] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v9/i26/7643.htm |
Number | Citing Articles |
1 |
Si-Cong Chen, Dong-Heng Ma, Jia-Jian Zhong. Combination therapy with toripalimab and anlotinib in advanced esophageal squamous cell carcinoma: A case report. World Journal of Clinical Cases 2023; 11(27): 6579-6586 doi: 10.12998/wjcc.v11.i27.6579
Abstract(242) |
Core Tip(120) |
Full Article(HTML)(486)
|
Full Article with Cover (PDF)-19348K(92)
|
Full Article (Word)-1830K(12)
|
Audio-348K(0)
|
Peer-Review Report-223K(14)
|
Answering Reviewers-333K(13)
|
Full Article (PDF)-19049K(35)
|
Full Article (XML)-59K(11)
|
Times Cited (0)
|
Total Visits (1463)
|
Open
|
2 |
Giandomenico Roviello, Melissa Bersanelli, Martina Catalano. The latest developments in biomarkers predicting response to immunotherapy. Immunotherapy 2022; 14(14): 1085 doi: 10.2217/imt-2022-0053
|
3 |
Lisa Schlicher, Luke G. Green, Andrea Romagnani, Florian Renner. Small molecule inhibitors for cancer immunotherapy and associated biomarkers – the current status. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1297175
|
4 |
Mariana Neves Amaral, Pedro Faísca, Hugo Alexandre Ferreira, Maria Manuela Gaspar, Catarina Pinto Reis. Current Insights and Progress in the Clinical Management of Head and Neck Cancer. Cancers 2022; 14(24): 6079 doi: 10.3390/cancers14246079
|
5 |
Yong-Po Zhang, Yue-Wei Tian, Jiang Geng, Xin-Hui Zhou, Meng-Ze Li, Guang-Huan Liu, Chun-Yan Gao, Ai-Qin Yue, Jin-Zhong Zhao, Wei-Jun Du. Nattokinase enhances the sensitivity of cancer cells to oxaliplatin through mitochondrial pathway and induction of apoptosis. Arabian Journal of Chemistry 2024; 17(1): 105478 doi: 10.1016/j.arabjc.2023.105478
|